The Daily Buyout

The archive

Every deal we've covered

1,792 deals tracked since Aug 26, 2026, worth $628B in announced deal value. Every link is free to read.

1,792 deals · $1.6B announced on this pagePage 48 of 90
$1.6BStrategic acquisitionHealthcare & Life SciencesOct 8, 2026

Viatris to buy Pacira BioSciences for $1.65B in cash

Viatris agreed to acquire Pacira BioSciences for $36.50 per share in cash, an aggregate equity value of $1.65 billion. Pacira sells the non-opioid pain drugs EXPAREL and ZILRETTA and generated about $746 million in revenue and $177 million in adjusted EBITDA over the last twelve months.